CLINICAL_TRIALS trial_result · 2024-10-28

Clinical Trial Update: A Study of Guselkumab for the Treatment of Participants With Crohn's Disease After Surgical Resection [Phase 3]

Phase 3 trial evaluating guselkumab for Crohn's disease after surgical resection was terminated, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Janssen Research & Development, LLC | Conditions: Crohn's Disease | Phase 3 | Status: TERMINATED | Results posted: 2024-10-28